Cargando…
Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global pandemic. Two doses of an inactivated SARS-CoV-2 vaccine (CoronaVac) have been shown to be insufficient to protect against variants of concern (VOCs), while viral vector vaccines remain protective against the infection....
Autores principales: | Pinpathomrat, Nawamin, Intapiboon, Porntip, Seepathomnarong, Purilap, Ongarj, Jomkwan, Sophonmanee, Ratchanon, Hengprakop, Jariya, Surasombatpattana, Smonrapat, Uppanisakorn, Supattra, Mahasirimongkol, Surakameth, Sawaengdee, Waritta, Phumiamorn, Supaporn, Sapsutthipas, Sompong, Kongkamol, Chanon, Ingviya, Thammasin, Sangsupawanich, Pasuree, Chusri, Sarunyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9106663/ https://www.ncbi.nlm.nih.gov/pubmed/35562372 http://dx.doi.org/10.1038/s41541-022-00475-z |
Ejemplares similares
-
Author Correction: Immunogenicity and safety of an intradermal ChAdOx1 nCoV-19 boost in a healthy population
por: Pinpathomrat, Nawamin, et al.
Publicado: (2022) -
Immunogenicity and Safety of an Intradermal BNT162b2 mRNA Vaccine Booster after Two Doses of Inactivated SARS-CoV-2 Vaccine in Healthy Population
por: Intapiboon, Porntip, et al.
Publicado: (2021) -
T-Cell Responses Induced by an Intradermal BNT162b2 mRNA Vaccine Booster Following Primary Vaccination with Inactivated SARS-CoV-2 Vaccine
por: Sophonmanee, Ratchanon, et al.
Publicado: (2022) -
Regulatory T Cells Decreased during Recovery from Mild COVID-19
por: Seepathomnarong, Purilap, et al.
Publicado: (2022) -
Impaired neutralizing antibodies and preserved cellular immunogenicity against SARS-CoV-2 in systemic autoimmune rheumatic diseases
por: Intapiboon, Porntip, et al.
Publicado: (2022)